With a steadfast vision and unrelenting drive to achieve a safe life for all, we embrace expertise, a global network, and integrity in our work. The leadership of The I Holdings will continue on the noble mission to enable improved accessibility of diagnostic technology and consequently the quality of life for people worldwide.
1st generation of diagnosis, disease gene diagnosis, Multiplex PCR Medical New Tech No. 1
2011-Now
The I Holdings Co., Ltd. [Founder / CEO]
– Fostering global new tech companies / Representative care of tech companies / Global enterprise link
– Disease diagnosis, on-site diagnostic platform development & development of diagnostic kits/equipment
Bio***(USA) [Founder / CEO]
– Uni. of Texas MD. Anderson Cancer Center Co-Working Director
– Korea biotech enterprise infrastructure support project / operation of new technology consultants – managing molecular diagnostics projects
Intron Bio Co., Ltd. (KOSDAQ listed company) [Founder / CEO]
– New antibiotic technology company / Molecular diagnostic company
1st generation of diagnosis, disease diagnosis expert / founder of Solgent Co., Ltd.
2020-Now
The I Holdings Co., Ltd. [CTO]
– R&D, Technical Marketing support
2000-2019
Solgent Co., Ltd. [Founder / CEO]
– 1st generation company for molecular diagnostics in Korea
– Reagent for genetic analysis / molecular diagnostic kit
– Established DNA test and test service system
Star Gene Co., Ltd. [Research Head]
– Developed infectious agent and genetic diagnostic kits
Korea Medical Systems Development [Team Leader]
– Developed Korea’s 1st ultra high-speed gene amplifier system
– Developed molecular diagnostic kit for infectious sources
EONE Laboratories (currently EONE Medical Foundation)
– Molecular diagnosis / gene diagnosis